about
Glycosylation of glycolipids in cancer: basis for development of novel therapeutic approachesThe role of infections in autoimmune diseaseGuillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosisZika virus and neurologic autoimmunity: the putative role of gangliosidesIntravenous immunoglobulin for multifocal motor neuropathyCellular and humoral immune abnormalities in Gulf War veteransZika virus-associated neurological disorders: a reviewGuillain–Barré syndrome in Colombia: where do we stand now?Neuroinflammation in the peripheral nerve: Cause, modulator, or bystander in peripheral neuropathies?Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodiesDifferentiating lower motor neuron syndromesSialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharidesMyelin-associated glycoprotein (MAG): past, present and beyondErythropoietin enhances nerve repair in anti-ganglioside antibody-mediated models of immune neuropathyBibliometric analysis of publications on Campylobacter: (2000-2015)Ganglioside inhibition of neurite outgrowth requires Nogo receptor function: identification of interaction sites and development of novel antagonistsChronic ataxic neuropathy mimicking dorsal midbrain syndrome.European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy.Complex gangliosides are apically sorted in polarized MDCK cells and internalized by clathrin-independent endocytosis.Comparative genotyping of Campylobacter jejuni strains from patients with Guillain-Barré syndrome in BangladeshPrevalence of anti-ganglioside antibodies and their clinical correlates with guillain-barré syndrome in Korea: a nationwide multicenter study.Uncovering cryptic glycan markers in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE).The role of chemokines in Guillain-Barré syndrome.Acute paretic syndrome in juvenile White Leghorn chickens resembles late stages of acute inflammatory demyelinating polyneuropathies in humans.Enteritis caused by Campylobacter jejuni followed by acute motor axonal neuropathy: a case report.N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.Intravenous immunoglobulin treatment in multifocal motor neuropathy.Identification of gene networks and pathways associated with Guillain-Barré syndrome.An update on pathobiologic roles of anti-glycan antibodies in Guillain-Barré syndrome.Pathogenesis and treatment of immune-mediated neuropathies.Bioengineered bugs expressing oligosaccharide receptor mimics: toxin-binding probiotics for treatment and prevention of enteric infectionsAnti-tissue transglutaminase IgA antibodies in peripheral neuropathy and motor neuronopathy.What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseases.Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.Fcγ receptor-mediated inflammation inhibits axon regeneration.Antibody responses to Mycoplasma pneumoniae: role in pathogenesis and diagnosis of encephalitis?The role of sulfoglucuronosyl glycosphingolipids in the pathogenesis of monoclonal IgM paraproteinemia and peripheral neuropathy.Competition between serum IgG, IgM, and IgA anti-glycan antibodiesGanglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases
P2860
Q21129299-410A055F-4762-4E68-B463-563034D94072Q22242631-A8FE2A16-7794-4CEC-80CA-043DAB807B5CQ22251013-D96A5B18-C65A-4DB7-9DDD-79B5904A1858Q23320717-CF80802E-C650-4C64-8FA3-EC7D78C3A45AQ24247007-8D5680B3-A61F-4468-BB67-25323A862561Q24530190-27F0B7F5-BBF5-4EA7-8545-6BE04B8162FBQ25115004-B4896BD5-50AF-4197-9625-1F2FF3FF65CFQ26252481-08291767-9F3C-4C56-A693-0CC27A16AAF5Q26801349-6EBFD98E-BD59-4540-B34C-9B2978F9EC81Q26864907-86E22D48-0465-438F-AA66-B5E2E041EAA0Q28070092-60470328-9787-40BD-B243-B0BB534DDED6Q28247592-9FDB69F7-41DC-426E-A8BB-4E1B957E2A9AQ28284415-8633C02A-60C7-49D2-BED5-50BEBEF88419Q28477706-792B147A-6F9B-4EB4-9703-F1626A8AB935Q28554580-0B4F7BBE-6278-419E-A4A9-C2C247A9572AQ28771761-E26EF7A7-72FB-4F99-ABA1-7B02E6707FB3Q30480804-61C06DAE-8BF9-4F81-AD2C-D604B75DA11AQ33235588-8854ECB9-F0F1-4CBB-8D8E-C73DA5984FFFQ33252355-30CD1C5C-6FCF-4421-ABB4-18756C1C2034Q33385837-DCEE461C-53D4-4732-8BFF-CC550AF64AD0Q33507527-54D2B3E3-E601-4AE7-A854-2093CFB2C4B2Q33594796-A9E8F792-D0EA-4DA6-8A2A-5175F7877C6CQ33605256-A433146D-3345-4E27-B6E4-E1F6084E3893Q33624382-58A0C920-2B10-43C8-B4F4-46BD681E0E63Q33672114-44498241-9773-4DB2-9C63-E2BEBBED736AQ33780392-68F7CDB6-12CB-4D13-890E-F7860FF5FEF7Q33882739-65D1E14C-713A-4E86-AD8A-44E5833D6D5AQ33903466-A5268081-4558-4AF6-B9EB-3AE848582089Q34130447-8B09EB14-462A-4071-A520-48B5951B4323Q34167468-3FE3A01B-0AEA-4E82-920A-9B212F63EE7CQ34409385-5B3EB0A2-35CC-473A-B486-AAFB94B2BE31Q34518407-70BF3888-56B5-46DF-A5D9-23333E53BE21Q34538126-D98CF0F7-0F5F-4739-B833-623063E98718Q34619162-7B9EB114-07A1-4036-9B7E-EB5D8D5B9231Q34720405-3A8C8DFE-F492-41E5-98BC-BFD4952BA323Q35093733-DA806A2A-4BC6-4DA3-BCEA-0E4EA75AD39BQ35191424-EC24C63B-9560-4C4F-93CA-186912AE2283Q35208842-10AAA163-0066-4F80-9679-B832F9A5BC08Q35217313-9B25EB6A-7E47-40AD-BB65-0407E96782ADQ35220367-2E4D6CA3-4FC8-4169-BBDC-C8401A0D0AB4
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Peripheral neuropathies and anti-glycolipid antibodies.
@ast
Peripheral neuropathies and anti-glycolipid antibodies.
@en
Peripheral neuropathies and anti-glycolipid antibodies.
@nl
type
label
Peripheral neuropathies and anti-glycolipid antibodies.
@ast
Peripheral neuropathies and anti-glycolipid antibodies.
@en
Peripheral neuropathies and anti-glycolipid antibodies.
@nl
prefLabel
Peripheral neuropathies and anti-glycolipid antibodies.
@ast
Peripheral neuropathies and anti-glycolipid antibodies.
@en
Peripheral neuropathies and anti-glycolipid antibodies.
@nl
P356
P1433
P1476
Peripheral neuropathies and anti-glycolipid antibodies.
@en
P2093
Hugh J Willison
P304
P356
10.1093/BRAIN/AWF272
P407
P577
2002-12-01T00:00:00Z